OLIG2 expression level could be used as an independent prognostic factor for patients with cerebellar Glioblastoma (cGBM). Clinics, [S. l.], v. 78, p. 100120, 2023. DOI: 10.1016/j.clinsp.2022.100120. Disponível em: https://www.journals.usp.br/clinics/article/view/213766.. Acesso em: 9 may. 2024.